Recent research and development of Antrodia cinnamomea
Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia cinnamomea is a treasured Taiwanese mushroom that has been used by aboriginal tribes for centuries to treat food intoxication and...
Saved in:
Published in | Pharmacology & therapeutics (Oxford) Vol. 139; no. 2; pp. 124 - 156 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.08.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia cinnamomea is a treasured Taiwanese mushroom that has been used by aboriginal tribes for centuries to treat food intoxication and to enhance liver functions. It was included in Asian folk medicine in the last few decades with remarkable results in treating inflammatory disorders, cancers, hypertension and hepatitis. This myriad of therapeutic activities encouraged several research groups to subject A. cinnamomea to intensive biological and phytochemical investigation, leading to the isolation of different classes of pharmacologically active secondary metabolites. The in vitro and in vivo biological results of the mushroom extracts and its active components revealed their potent cytotoxic, anti-inflammatory and hepatoprotective activities. The aim of this study is to review recent reports on the biological activities of A. cinnamomea extracts and its active components; quality control protocols; synthetic methodologies for the preparation of active components; developed culture techniques; phylogenetic analysis and gene cloning. This study also tackles major challenges facing future expansion of A. cinnamomea production. |
---|---|
AbstractList | Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia cinnamomea is a treasured Taiwanese mushroom that has been used by aboriginal tribes for centuries to treat food intoxication and to enhance liver functions. It was included in Asian folk medicine in the last few decades with remarkable results in treating inflammatory disorders, cancers, hypertension and hepatitis. This myriad of therapeutic activities encouraged several research groups to subject A. cinnamomea to intensive biological and phytochemical investigation, leading to the isolation of different classes of pharmacologically active secondary metabolites. The in vitro and in vivo biological results of the mushroom extracts and its active components revealed their potent cytotoxic, anti-inflammatory and hepatoprotective activities. The aim of this study is to review recent reports on the biological activities of A. cinnamomea extracts and its active components; quality control protocols; synthetic methodologies for the preparation of active components; developed culture techniques; phylogenetic analysis and gene cloning. This study also tackles major challenges facing future expansion of A. cinnamomea production. Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia cinnamomea is a treasured Taiwanese mushroom that has been used by aboriginal tribes for centuries to treat food intoxication and to enhance liver functions. It was included in Asian folk medicine in the last few decades with remarkable results in treating inflammatory disorders, cancers, hypertension and hepatitis. This myriad of therapeutic activities encouraged several research groups to subject A. cinnamomea to intensive biological and phytochemical investigation, leading to the isolation of different classes of pharmacologically active secondary metabolites. The in vitro and in vivo biological results of the mushroom extracts and its active components revealed their potent cytotoxic, anti-inflammatory and hepatoprotective activities. The aim of this study is to review recent reports on the biological activities of A. cinnamomea extracts and its active components; quality control protocols; synthetic methodologies for the preparation of active components; developed culture techniques; phylogenetic analysis and gene cloning. This study also tackles major challenges facing future expansion of A. cinnamomea production.Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia cinnamomea is a treasured Taiwanese mushroom that has been used by aboriginal tribes for centuries to treat food intoxication and to enhance liver functions. It was included in Asian folk medicine in the last few decades with remarkable results in treating inflammatory disorders, cancers, hypertension and hepatitis. This myriad of therapeutic activities encouraged several research groups to subject A. cinnamomea to intensive biological and phytochemical investigation, leading to the isolation of different classes of pharmacologically active secondary metabolites. The in vitro and in vivo biological results of the mushroom extracts and its active components revealed their potent cytotoxic, anti-inflammatory and hepatoprotective activities. The aim of this study is to review recent reports on the biological activities of A. cinnamomea extracts and its active components; quality control protocols; synthetic methodologies for the preparation of active components; developed culture techniques; phylogenetic analysis and gene cloning. This study also tackles major challenges facing future expansion of A. cinnamomea production. |
Author | Chang, Fang-Rong Hsu, Yu-Ming Lu, Mei-Chin Chen, Chieh-Fu Lai, Kuei-Hung Chiu, Ching-Peng El-Shazly, Mohamed Du, Ying-Chi Wu, Tung-Ying Chang, Tun-Tschu Wu, Yang-Chang |
Author_xml | – sequence: 1 givenname: Mei-Chin surname: Lu fullname: Lu, Mei-Chin organization: Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Taiwan – sequence: 2 givenname: Mohamed surname: El-Shazly fullname: El-Shazly, Mohamed – sequence: 3 givenname: Tung-Ying surname: Wu fullname: Wu, Tung-Ying – sequence: 4 givenname: Ying-Chi surname: Du fullname: Du, Ying-Chi – sequence: 5 givenname: Tun-Tschu surname: Chang fullname: Chang, Tun-Tschu – sequence: 6 givenname: Chieh-Fu surname: Chen fullname: Chen, Chieh-Fu – sequence: 7 givenname: Yu-Ming surname: Hsu fullname: Hsu, Yu-Ming – sequence: 8 givenname: Kuei-Hung surname: Lai fullname: Lai, Kuei-Hung – sequence: 9 givenname: Ching-Peng surname: Chiu fullname: Chiu, Ching-Peng – sequence: 10 givenname: Fang-Rong surname: Chang fullname: Chang, Fang-Rong – sequence: 11 givenname: Yang-Chang surname: Wu fullname: Wu, Yang-Chang |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23563277$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkEtLw0AUhQep2If-BcnSTeKdRzKZZSm-oCBIF-7CzeSGpiQzcZII_ntbrOBOOHAOnI-zOEs2c94RYxGHhAPP7g9Jv8fQjXsKmAjgMgGVAPALtuC5NvGReZ_9yXO2HIYDACgF4orNhUwzKbResOyNLLkxCjQQBruP0FVRRZ_U-r47Fb6O1m4Mvmowso1z2PmO8Jpd1tgOdHP2Fds9Puw2z_H29ells97GvVBqjFHJGnMQua41lqnKpCJ1kiHBrdVoMywNoDAlgqylhrSuUmOMFZSClit29zPbB_8x0TAWXTNYalt05Keh4FrKVGgj8v9RqQVoozN1RG_P6FR2VBV9aDoMX8XvK_IbVLVoLg |
ContentType | Journal Article |
Copyright | Copyright © 2013 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: Copyright © 2013 Elsevier Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
DOI | 10.1016/j.pharmthera.2013.04.001 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1879-016X |
EndPage | 156 |
ExternalDocumentID | 23563277 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | --- --K --M .GJ .~1 0R~ 123 1B1 1RT 1~. 1~5 29O 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO ABFNM ABMAC ABWVN ABXDB ABZDS ACDAQ ACGFO ACIUM ACRLP ACRPL ADBBV ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AFFNX AFJKZ AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AKRWK ALCLG ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CGR CS3 CUY CVF DU5 EBS ECM EFJIC EIF EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HVGLF HZ~ IHE J1W K-O KOM L7B M34 M41 MO0 N9A NPM O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SPT SSH SSP SSZ T5K TEORI WUQ Y6R ZGI ZXP ~G- 7X8 AAYWO ACVFH ADCNI AEUPX AFPUW AGCQF AGRNS AIIUN AKBMS AKYEP 7S9 EFKBS L.6 |
ID | FETCH-LOGICAL-p244t-a43fa80287f7ab54634e44e449e21cc7ac6ab90a29ba03f3705fd5999c2e5073 |
ISSN | 1879-016X 0163-7258 |
IngestDate | Sun Aug 24 04:04:27 EDT 2025 Fri Jul 11 14:18:48 EDT 2025 Thu Apr 03 06:56:49 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | Copyright © 2013 Elsevier Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p244t-a43fa80287f7ab54634e44e449e21cc7ac6ab90a29ba03f3705fd5999c2e5073 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
PMID | 23563277 |
PQID | 1372079764 |
PQPubID | 23479 |
PageCount | 33 |
ParticipantIDs | proquest_miscellaneous_1733527928 proquest_miscellaneous_1372079764 pubmed_primary_23563277 |
PublicationCentury | 2000 |
PublicationDate | 2013-Aug 20130801 |
PublicationDateYYYYMMDD | 2013-08-01 |
PublicationDate_xml | – month: 08 year: 2013 text: 2013-Aug |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Pharmacology & therapeutics (Oxford) |
PublicationTitleAlternate | Pharmacol Ther |
PublicationYear | 2013 |
SSID | ssj0004402 |
Score | 2.4917457 |
SecondaryResourceType | review_article |
Snippet | Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory... |
SourceID | proquest pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 124 |
SubjectTerms | Animals anti-inflammatory activity Anti-Inflammatory Agents - pharmacology Antineoplastic Agents - pharmacology Antrodia - chemistry Antrodia - physiology chemoprevention Cinnamomum Complex Mixtures - pharmacology cytotoxicity food intoxication hepatitis Humans hypertension liver medicinal fungi molecular cloning mushrooms neoplasms Phylogeny Protective Agents - pharmacology quality control research and development secondary metabolites Taiwanofungus camphoratus traditional medicine |
Title | Recent research and development of Antrodia cinnamomea |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23563277 https://www.proquest.com/docview/1372079764 https://www.proquest.com/docview/1733527928 |
Volume | 139 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5a99JLSV95tWULJZd6jbW78mqPpTiEYqeBKOCexGq9wglYMq19SA757ZnZlSqVusUtGGEWW6_vYzQzmpmPkA_c5NwVSrAocTGTEPcwPXSWRUpop60rIq91OD0fnV3JL7N41qqi-u6SdT6wd1v7Sv4HVVgDXLFL9h-Q_blTWIDvgC9sAWHY7oQx-Hz4Kr8e2BN61OZtFZD3MrESHTjw0V6XpVlWS2e6_uhFO7k6lM50-rF8PjY0FHbyBZONz6G6a4bS223pB7tcmLsgWz2tFmZZN02hvff_SMGqsG_Ng9K7zt78wwruqZt9QCWIpMk-BIOZKKy38mqE8DzZstZY2TCzqKYT79jMKDRR_2bLQ1rhZrDCO-GvHivxhJ9MW5_CL-Ozz79mp1eTSZaOZ-lj8oRD3ICSFoP7tuZHylCE2pxgXdoVCv62H-fPkYf3QNI98qwOHeinwIPn5JErX5CTGsHbPk070PXpCe1i-5KMAlloQxYKZKEdstCqoA1ZaEuWVyQ9Haefz1gtmsFW4KmtmZGiMAl4japQJkexA-kkfrTjkbXK2JHJ9dBwnZuhKIQaxsU8hjDBcgexgXhNemVVugNCOYdoIi94ElkckjhPjI7lHMJ_7iDI0faQvG_uTAY2CV80mdJVmx9ZhNJHChxd-ZffKOz2U5onh2Q_3NZsFQasZFzEIwH4He1whGPytOXlG9Jbf9-4t-AnrvN3HvsHsStn1Q |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+research+and+development+of+Antrodia+cinnamomea&rft.jtitle=Pharmacology+%26+therapeutics+%28Oxford%29&rft.au=Lu%2C+Mei-Chin&rft.au=El-Shazly%2C+Mohamed&rft.au=Wu%2C+Tung-Ying&rft.au=Du%2C+Ying-Chi&rft.date=2013-08-01&rft.issn=1879-016X&rft.eissn=1879-016X&rft.volume=139&rft.issue=2&rft.spage=124&rft_id=info:doi/10.1016%2Fj.pharmthera.2013.04.001&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1879-016X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1879-016X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1879-016X&client=summon |